ArticleJournal of advanced research2026
SOD1 regulates CXCR4 transcription in cortical neurons for establishment of cerebral ischemic tolerance.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUnderstanding of cerebral ischemic tolerance could provide important insight into viable neuroprotective strategies against ischemic stroke.
objectivesTo elucidate the function of superoxide dismutase 1 (SOD1) in cellular tolerance to ischemia and its underlying molecular mechanism.
methodsTwo-vessel occlusion of the carotid arteries and oxygen-glucose deprivation were used for modelling global ischemic preconditioning (IPC) and in vitro ischemic preconditioning models, respectively. Cleavage-Under-Targets-And-Tagmentation (CUT&Tag)-sequencing analysis was performed for mapping SOD1-whole genome-binding sites in cultured cortical neurons in the in vitro ischemic tolerance model. Cell fractionation and immunofluorescent staining were used for analyzing the subcellular localization of SOD1 in tissue and cultured neuronal cells.
resultsHere, we showed that cortex, striatum and thalamus, but not hippocampus, exhibited ischemic tolerance phenotypes after global IPC. Intriguingly, we found that SOD1 was accumulated in the cellular nucleus after IPC. Notably, cortex was the most responsive brain region in terms of neuronal SOD1 nuclear translocation in response to IPC. We further confirmed these observations in the cultured cortical neurons in the in vitro ischemic tolerance model. CUT&Tag-sequencing analysis revealed that SOD1 bound to promoter regions in cortical neurons, and its binding was significantly altered after IPC stimulus. Notably, SOD1 was most prominently accumulated at the gene promoter of CXCR4 after IPC, which was correlated with transcriptional activation of CXCR4. Furthermore, we found that upregulation of CXCR4 expression was accompanied by modulation of gene expression resulting in anti-apoptosis. Moreover, we showed that pharmacological manipulation of CXCR4 activity could regulate cell viability through STAT3 in cortical neurons. Finally, we found that SOD1 was required for CXCR4-STAT3-mediated apoptosis in the IPC-induced ischemic tolerance.
conclusionTherefore, these results demonstrate a non-canonical transcription-regulatory function of SOD1 which regulates CXCR4-STAT3 pathway to confer ischemic tolerance in cortical neurons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.